Clinical Trial Update: Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial (COMBINE) evaluating biologics to improve outcomes of oral immunotherapy for food and peanut allergies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy
• Peanut Allergy

Snippet

Sponsor: Stanford University | Conditions: Hypersensitivity, Food Allergy | Phase 2 | Status: COMPLETED